UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 204

Sortiert nach

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum

Journal of thrombosis and thrombolysis, 2020-07, Vol.50 (1), p.72-81

2020

Link zum Volltext

Verfügbarkeit prüfen

Patterns and Predictors of Peripherally Inserted Central Catheter Occlusion: The 3P-O Study

Journal of vascular and interventional radiology, 2017-05, Vol.28 (5), p.749-756.e2

2017

Link zum Volltext

Verfügbarkeit prüfen

Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical Patients

The American journal of medicine, 2016-09, Vol.129 (9), p.1001.e9-1001.e18

2016

Link zum Volltext

Verfügbarkeit prüfen

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors

American journal of hematology, 2012-05, Vol.87 (S1), p.S141-S145

2012

Link zum Volltext

Verfügbarkeit prüfen

Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism

Journal of thrombosis and thrombolysis, 2016, Vol.41 (1), p.187-205

2016

Link zum Volltext

Verfügbarkeit prüfen

Preclinical and Clinical Data for Factor Xa and “Universal” Reversal Agents

The American journal of medicine, 2016-11, Vol.129 (11), p.S80-S88

2016

Link zum Volltext

Verfügbarkeit prüfen

Preclinical and clinical data for factor Xa and “Universal” reversal agents

The American journal of emergency medicine, 2016-11, Vol.34 (11), p.39-45

2016

Link zum Volltext

Verfügbarkeit prüfen

Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study

Journal of the American College of Cardiology, 2002-01, Vol.39 (1), p.60-69

2002

Link zum Volltext

Verfügbarkeit prüfen

Eligibility for Posthospitalization Venous Thromboembolism Prophylaxis in Hospitalized Patients With COVID-19: A Retrospective Cohort Study

Journal of the American Heart Association, 2022-10, Vol.11 (19), p.e025914-e025914

2022

Link zum Volltext

Verfügbarkeit prüfen

Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real-World Practice Mirrors Guideline Recommendations

Journal of the American Heart Association, 2022-11, Vol.11 (21), p.e025471

2022

Link zum Volltext

Verfügbarkeit prüfen

Leadership & Professional Development: Lessons Learned From the Other Side of the Stethoscope (and Endotracheal Tube)

Journal of hospital medicine, 2021-03, Vol.16 (3), p.164-164

Kaatz, Scott

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID‐19 and venous thromboembolism: A narrative review

Research and practice in thrombosis and haemostasis, 2022-02, Vol.6 (2), p.e12666-n/a, Article e12666

2022

Link zum Volltext

Verfügbarkeit prüfen

Correcting Inappropriate Prescribing of Direct Oral Anticoagulants: A Population Health Approach

Journal of the American Heart Association, 2020-11, Vol.9 (22), p.e016949-e016949

2020

Link zum Volltext

Verfügbarkeit prüfen

Creatinine monitoring patterns in the setting of direct oral anticoagulant therapy for non-valvular atrial fibrillation

Journal of thrombosis and thrombolysis, 2019-10, Vol.48 (3), p.500-505

2019

Link zum Volltext

Verfügbarkeit prüfen

Barriers and facilitators to reducing frequent laboratory testing for patients who are stable on warfarin: a mixed methods study of de-implementation in five anticoagulation clinics

Implementation science : IS, 2017-07, Vol.12 (1), p.87-87, Article 87

2017

Link zum Volltext

Verfügbarkeit prüfen

Institutional Structures and Processes to Support Sepsis Care: A Multihospital Study

Critical care explorations, 2023-11, Vol.5 (11), p.e1004-e1004

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk of Recurrences in Patients With Unprovoked VTE Who Continued vs Discontinued Rivaroxaban Therapy After 3-Month Therapy

Chest, 2016-10, Vol.150 (4), p.1155A-1155A

2016

Link zum Volltext

Verfügbarkeit prüfen

Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry)

The American journal of cardiology, 2008-10, Vol.102 (7), p.883-889

2008

Link zum Volltext

Verfügbarkeit prüfen

Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE

Clinical therapeutics, 2017-07, Vol.39 (7), p.1396-1408

2017

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 versus HIT hypercoagulability

Thrombosis research, 2020-12, Vol.196, p.38-51

2020

Link zum Volltext

Verfügbarkeit prüfen

Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum

American journal of hematology, 2019-06, Vol.94 (6), p.697-709

2019

Link zum Volltext

Verfügbarkeit prüfen

Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists: Systematic Review and Meta-Analysis of Bleeding and Thromboembolic Rates

Circulation (New York, N.Y.), 2012-09, Vol.126 (13), p.1630-1639

2012

Link zum Volltext

Verfügbarkeit prüfen

Perioperative consultative hematology: can you clear my patient for a procedure?

Hematology, 2021-12, Vol.2021 (1), p.521-528

2021

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous Thyroid Hemorrhage on Chronic Anticoagulation Therapy

Clinics and practice, 2017-02, Vol.7 (1), p.932

2017

Link zum Volltext

Verfügbarkeit prüfen

Reversal of target-specific oral anticoagulants

Journal of thrombosis and thrombolysis, 2013-08, Vol.36 (2), p.195-202

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(181)

Publikationsform

Artikel
(203)
Buchkapitel
(1)

Sprache

Englisch
(203)
Japanisch
(12)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum

Patterns and Predictors of Peripherally Inserted Central Catheter Occlusion: The 3P-O Study

Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical Patients

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors

Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism

Preclinical and Clinical Data for Factor Xa and “Universal” Reversal Agents

Preclinical and clinical data for factor Xa and “Universal” reversal agents

Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study

Eligibility for Posthospitalization Venous Thromboembolism Prophylaxis in Hospitalized Patients With COVID-19: A Retrospective Cohort Study

Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real-World Practice Mirrors Guideline Recommendations

Leadership & Professional Development: Lessons Learned From the Other Side of the Stethoscope (and Endotracheal Tube)

COVID‐19 and venous thromboembolism: A narrative review

Correcting Inappropriate Prescribing of Direct Oral Anticoagulants: A Population Health Approach

Creatinine monitoring patterns in the setting of direct oral anticoagulant therapy for non-valvular atrial fibrillation

Barriers and facilitators to reducing frequent laboratory testing for patients who are stable on warfarin: a mixed methods study of de-implementation in five anticoagulation clinics

Institutional Structures and Processes to Support Sepsis Care: A Multihospital Study

Risk of Recurrences in Patients With Unprovoked VTE Who Continued vs Discontinued Rivaroxaban Therapy After 3-Month Therapy

Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry)

Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE

COVID-19 versus HIT hypercoagulability

Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum

Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists: Systematic Review and Meta-Analysis of Bleeding and Thromboembolic Rates

Perioperative consultative hematology: can you clear my patient for a procedure?

Spontaneous Thyroid Hemorrhage on Chronic Anticoagulation Therapy

Reversal of target-specific oral anticoagulants

Suchergebnisse filtern